Wentao Fu

3PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 04, 2024
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma.

Michael H Brave, William F Maguire, Chana Weinstock

|May 29, 2024
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer.

Michael J Fusco, Sandra J Casak, Sirisha L Mushti

|Jun 15, 2023
FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer.

Sandra J Casak, M Naomi Horiba, Mengdie Yuan

Pageof 1

Frequent Collaborators

3 joint publications

Richard Pazdur

3 joint publications

Paul G Kluetz

2 joint publications

Sandra J Casak

2 joint publications

Nam Atiqur Rahman